Clinical Trial Details

EORTC-1403-STBSG

Back to Clinical Trials Database

International Randomised Controlled Trial of Chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 10-Mar-2016
Date Step1 close: 03-Dec-2021
Data management at EORTC No
Design Phase 2-3
Randomized open label
Targeted Sample size EORTC Groups: 100 - All Groups: 500
Treatment Drug
Cyclophosphamide, Docetaxel, Gemcitabine, Ifosfamide, Irinotecan, Temozolomide, Topotecan
Study Staff Uta Dirksen (Study Coordinator) , Universitaetsklinikum - Essen, Essen
Martin McCabe (Study Coordinator) , The Christie NHS Foundation Trust, Manchester
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Bianca Colleoni (Clinical Operations Manager) , EORTC Headquarters, Brussels
Niels Lema (Clinical Data Expert) , EORTC Headquarters, Brussels
Saskia Litiere (Statistician) , EORTC Headquarters, Brussels
Juliette Ly (Project Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Zara Nasir (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Miriam Presas (Junior RAM) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Ionela Stanciu (Clinical Operations Manager) , EORTC Headquarters, Brussels
Zineb Wadid (Lead CRA) , EORTC Headquarters, Brussels
Xiao Mang Zhou (Junior RAM) , EORTC Headquarters, Brussels
Type of cancer Ewing Sarcoma
Participating groups EORTC Soft Tissue and Bone Sarcoma Group
Scandinavian Sarcoma Group
Italian Sarcoma Group
Gesellschaft fuer Paediatrische Onko. & Haemato. - Germany
Grupo Espanol de Investigacion en sarcomas
University of Birmingham - CRUK
Swiss Paediatric Oncology Group
Recruiting centers APHP Sorbonne Univ - Hopital Armand Trousseau (PARIS, France)
Amsterdam UMC - Locatie AMC (Amsterdam, Netherlands)
CHC - Clinique de l'Esperance (Saint-Nicolas (Montegnee), Belgium)
CHC MontLegia (Liege, Belgium)
CHRU de Nancy - Hopitaux De Brabois (VANDOEUVRE LES NANCY CEDEX, France)
CHU De Toulouse - Hopital Des Enfants (TOULOUSE CEDEX 3, France)
CHU Montpellier-Hopital Arnaud De Villeneuve (MONTPELLIER CEDEX 5, France)
CHU de Nantes - Hopital femme-enfant-adolescent (NANTES CEDEX 1, France)
CHU de Nice - Hopital De L'Archet (NICE, France)
CHU de Rouen - Hopital Charles Nicolle (ROUEN CEDEX, France)
CHU de Tours - Hopital Bretonneau (Tours, France)
Centre Georges-Francois-Leclerc (DIJON CEDEX, France)
Centre Henri Becquerel (ROUEN CEDEX, France)
Centre Leon Berard (Lyon, France)
Centre Oscar Lambret (LILLE CEDEX, France)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
Gustave Roussy (VILLEJUIF CEDEX, France)
Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France)
Hopitaux Universitaires de Strasbourg - Hautepierre (Strasbourg Cedex 1, France)
Institut Bergonie (Bordeaux, France)
Institut Curie- Hopital de Paris (PARIS CEDEX 05, France)
Institut Jules Bordet (Anderlecht, Belgium)
Institut de Cancerologie de la Loire Lucien Neuwirth (Saint Priest en Jarez, France)
Institut de Cancerologie de l’Ouest (ICO) - Angers (ANGERS CEDEX 02, France)
Institut de Cancerologie de l’Ouest (ICO) - Saint Herblain (Saint Herblain CEDEX, France)
Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France)
Leiden University Medical Centre (Leiden, Netherlands)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
Military Hospital - State Health Centre (Budapest, Hungary)
Radboud University Medical Center Nijmegen (Nijmegen, Netherlands)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
Universitair Ziekenhuis Brussel (Brussels, Belgium)
Universitair Ziekenhuis Gent (Gent, Belgium)
University Hospital Motol (Prague, Czech Republic)
University Medical Center Groningen (Groningen, Netherlands)
Protocol summary http://clinicaltrials.gov/study/
NCT number
EudraCT 2014-000259-99
Financial Support EU Grant